Evolving drug trends and spotlight on xylazine

During this webinar, our toxicology experts provide an informative and fascinating review of the ever-changing landscape of the illicit drug market. Labcorp’s R&D scientific director shares insights related to the history of designer drugs, new uses for age-old drugs and how Labcorp responds to evolving drug trends. Most importantly we discuss the relevance of these drug trends in routine clinical practice.

This webinar includes:

• History of drug trends
• Spotlight - Xylazine and other novel agents
• Impact of evolving trends on your clinical practice
• Q&A with the presenters

Presenters: 

Hemamalini Ketha, PhD, NRCC, SC (ASCP), FAACC
Discipline Director, Clinical Toxicology

Gregory Clark Janis, MS 
R&D Technical Director, Director of Mass Spectrometry